-
Cevipabulin fumarate
- names:
Cevipabulin fumarate
- CAS号:
849550-67-0
MDL Number: - MF(分子式): C22H22ClF5N6O5 MW(分子量): 580.89
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM002554-10mg | 10mg | 99.08% | ¥ 11988.00 | ¥ 11988.00 | 2-3天 | ¥ 0.00 | ||
| YZM002554-5mg | 5mg | 99.08% | ¥ 2184.00 | ¥ 2184.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 849550-67-0 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C22H22ClF5N6O5 |
| 分子量 Molecular Weight | 580.89 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度50 mg/mL(86.07 mM;Need ultrasonic) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
Cevipabulin fumarate(CAS:849550-67-0)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | Cevipabulin fumarate (TTI-237 fumarate) 是一种有效的微管活性的、口服有效的抗肿瘤化合物,可抑制 [3H]长春碱与微管蛋白的结合,对人癌细胞的IC50值为 18-40 nM |
| Introduction | Cevipabulin fumarate (TTI37 fumarate) is an oral, microtubulective, antitumor compound and inhibits the binding of [3H]NSC 49842 to tubulin, with anIC50of 180 nM for cytotoxicity in human tumor cell line[2]. |
| Application1 | |
| Application2 | |
| Application3 |
Cevipabulin fumarate (TTI-237 fumarate) 是一种有效的微管活性的、口服有效的抗肿瘤化合物,可抑制 [3H]长春碱与微管蛋白的结合,对人癌细胞的IC50值为 18-40 nM。Cevipabulin fumarate (TTI-237 fumarate) is an oral, microtubule-active, antitumor compound and inhibits the binding of [3H]NSC 49842 to tubulin, with anIC50of 18-40 nM for cytotoxicity in human tumor cell line[1][2].
【1】.Beyer CF, et al. TTI-237: a novel microtubule-active compound with in vivo antitumor activity. Cancer Res. 2008 Apr 1;68(7):2292-300.
【2】.Beyer CF, et al. The microtubule-active antitumor compound TTI-237 has both DB01229-like and Leurocristine-like properties. Cancer Chemother Pharmacol. 2009 Sep;64(4):681-9.
【2】.Beyer CF, et al. The microtubule-active antitumor compound TTI-237 has both DB01229-like and Leurocristine-like properties. Cancer Chemother Pharmacol. 2009 Sep;64(4):681-9.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


